Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 12
1967 7
1968 12
1969 11
1970 21
1971 15
1972 21
1973 26
1974 21
1975 21
1976 26
1977 27
1978 14
1979 23
1980 44
1981 37
1982 50
1983 58
1984 59
1985 68
1986 83
1987 71
1988 80
1989 104
1990 69
1991 98
1992 76
1993 60
1994 94
1995 89
1996 63
1997 71
1998 88
1999 88
2000 95
2001 107
2002 96
2003 87
2004 78
2005 90
2006 88
2007 92
2008 69
2009 70
2010 61
2011 56
2012 57
2013 59
2014 62
2015 51
2016 31
2017 47
2018 41
2019 42
2020 23
2021 18
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

3,004 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of the Effect of 5 Different Treatment Options for Managing Patellar Tendinopathy: A Secondary Analysis.
van Rijn D, van den Akker-Scheek I, Steunebrink M, Diercks RL, Zwerver J, van der Worp H. van Rijn D, et al. Clin J Sport Med. 2019 May;29(3):181-187. doi: 10.1097/JSM.0000000000000520. Clin J Sport Med. 2019. PMID: 31033610 Clinical Trial.
INTERVENTIONS: Participants were divided into 5 groups, based on the treatment they received: Extracorporeal shockwave therapy (ESWT) (n = 31), ESWT plus eccentric training (n = 43), eccentric training (n = 17), topical glyceryl trinitrate patch plus eccentric train …
INTERVENTIONS: Participants were divided into 5 groups, based on the treatment they received: Extracorporeal shockwave therapy (ESWT) (n = 3 …
Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke.
Appleton JP, Woodhouse LJ, Bereczki D, Berge E, Christensen HK, Collins R, Gommans J, Ntaios G, Ozturk S, Szatmari S, Wardlaw JM, Sprigg N, Rothwell PM, Bath PM; ENOS Investigators. Appleton JP, et al. Stroke. 2019 Feb;50(2):405-412. doi: 10.1161/STROKEAHA.118.023190. Stroke. 2019. PMID: 30626285 Free PMC article. Clinical Trial.
Background and Purpose- Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynam …
Background and Purpose- Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product …
Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial.
van den Berg SA, Dippel DWJ, Hofmeijer J, Fransen PSS, Caminada K, Siegers A, Kruyt ND, Kerkhoff H, de Leeuw FE, Nederkoorn PJ, van der Worp HB; MR ASAP Investigators. van den Berg SA, et al. Trials. 2019 Jun 26;20(1):383. doi: 10.1186/s13063-019-3419-z. Trials. 2019. PMID: 31242931 Free PMC article. Clinical Trial.
BACKGROUND: Some studies have suggested that transdermal administration of glyceryl trinitrate (GTN; nitroglycerin) in the first few hours after symptom onset increases the chance of a favourable outcome after ischaemic stroke or intracerebral haemorrhage, po …
BACKGROUND: Some studies have suggested that transdermal administration of glyceryl trinitrate (GTN; nitroglycerin) in …
Comparative pharmacokinetics and bioavailability of nitroglycerin and its metabolites from Transderm-Nitro, Nitrodisc, and Nitro-Dur II systems using a stable-isotope technique.
Sun JX, Piraino AJ, Morgan JM, Joshi JC, Cipriano A, Chan K, Redalieu E. Sun JX, et al. J Clin Pharmacol. 1995 Apr;35(4):390-7. doi: 10.1002/j.1552-4604.1995.tb04079.x. J Clin Pharmacol. 1995. PMID: 7650229 Clinical Trial.
The pharmacokinetics and bioavailability of nitroglycerin (GTN) and its metabolites, 1,2-glyceryl dinitrate (1,2-GDN) and 1,3-glyceryl dinitrate (1,3-GDN), were compared after a single 14-hour application of Transderm-Nitro (Ciba-Geigy, Summit, NJ), Nitrodisc …
The pharmacokinetics and bioavailability of nitroglycerin (GTN) and its metabolites, 1,2-glyceryl dinitrate (1,2-GDN) and 1,3- …
Acute hypoxaemia and vascular function in healthy humans.
Lewis NCS, Bain AR, Wildfong KW, Green DJ, Ainslie PN. Lewis NCS, et al. Exp Physiol. 2017 Dec 1;102(12):1635-1646. doi: 10.1113/EP086532. Epub 2017 Oct 25. Exp Physiol. 2017. PMID: 28901662 Free article. Clinical Trial.
Additionally, we assessed whether smooth muscle vasodilatory capacity [glyceryl trinitrate (GTN)-induced dilatation] is impaired during acute hypoxic exposure. ...Endothelium-dependent flow-mediated dilatation (FMD) and endothelium-independent dilatation [induced wi …
Additionally, we assessed whether smooth muscle vasodilatory capacity [glyceryl trinitrate (GTN)-induced dilatation] is impair …
Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial.
Bath PM, Woodhouse LJ, Krishnan K, Appleton JP, Anderson CS, Berge E, Cala L, Dixon M, England TJ, Godolphin PJ, Hepburn T, Mair G, Montgomery AA, Phillips SJ, Potter J, Price CI, Randall M, Robinson TG, Roffe C, Rothwell PM, Sandset EC, Sanossian N, Saver JL, Siriwardena AN, Venables G, Wardlaw JM, Sprigg N. Bath PM, et al. Stroke. 2019 Nov;50(11):3064-3071. doi: 10.1161/STROKEAHA.119.026389. Epub 2019 Oct 7. Stroke. 2019. PMID: 31587658 Free PMC article. Clinical Trial.
Background and Purpose- Pilot trials suggest that glyceryl trinitrate (GTN; nitroglycerin) may improve outcome when administered early after stroke onset. ...
Background and Purpose- Pilot trials suggest that glyceryl trinitrate (GTN; nitroglycerin) may improve outcome when adm …
Transdermal nitroglycerin: clinical and pharmacokinetic consequences of renewing the patch and the application site.
Klemsdal TO, Mundal HH, Bredesen JE, Gjesdal K. Klemsdal TO, et al. Eur J Clin Pharmacol. 1997;52(5):379-81. doi: 10.1007/s002280050304. Eur J Clin Pharmacol. 1997. PMID: 9272407 Clinical Trial.
OBJECTIVE: We examined whether nitroglycerin (glyceryl trinitrate, GTN) patch treatment for 24 h could induce local cutaneous changes that impaired drug delivery and clinical efficacy. ...
OBJECTIVE: We examined whether nitroglycerin (glyceryl trinitrate, GTN) patch treatment for 24 h could induce local cut …
Associations between change in blood pressure and functional outcome, early events and death: results from the Efficacy of Nitric Oxide in Stroke trial.
Sandset EC, Appleton JP, Berge E, Christensen H, Gommans J, Krishnan K, Ntaios G, Phillips S, Pocock S, Sprigg N, Woodhouse LJ, Bath PM; ENOS trial investigators*. Sandset EC, et al. J Hypertens. 2019 Oct;37(10):2104-2109. doi: 10.1097/HJH.0000000000002154. J Hypertens. 2019. PMID: 31246895 Free PMC article. Clinical Trial.
METHODS: Analyses used data from the Efficacy of Nitric Oxide in Stroke trial, a multicentre randomized single-masked and outcome-masked trial of glyceryl trinitrate vs. no glyceryl trinitrate in 4011 patients recruited within 48 h of an ischaemic or h …
METHODS: Analyses used data from the Efficacy of Nitric Oxide in Stroke trial, a multicentre randomized single-masked and outcome-masked tri …
Comparative clinical trial of the tolerability, patient acceptability and efficacy of two transdermal glyceryl trinitrate patches ('Deponit' 5 and 'Transiderm-Nitro' 5) in patients with angina pectoris.
Vallé-Jones C, O'Hara J, O'Hara H. Vallé-Jones C, et al. Curr Med Res Opin. 1989;11(5):331-9. doi: 10.1185/03007998909115215. Curr Med Res Opin. 1989. PMID: 2495215 Clinical Trial.
A randomized two-period crossover trial was carried out to compare the efficacy, tolerability and patient acceptability of two transdermal ('patch') formulations of glyceryl trinitrate. 'Deponit' 5 and 'Transiderm-Nitro' 5, both designed to deliver 5 mg glyceryl
A randomized two-period crossover trial was carried out to compare the efficacy, tolerability and patient acceptability of two transdermal ( …
Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.
Sorkin EM, Brogden RN, Romankiewicz JA. Sorkin EM, et al. Drugs. 1984 Jan;27(1):45-80. doi: 10.2165/00003495-198427010-00003. Drugs. 1984. PMID: 6420139 Review.
The recently introduced preparation of intravenous glyceryl trinitrate (nitroglycerin) provides a rapid steady therapeutic blood concentration of nitrates during continuous infusion. Intravenous glyceryl trinitrate causes venodilation at low dos …
The recently introduced preparation of intravenous glyceryl trinitrate (nitroglycerin) provides a rapid steady therapeu …
3,004 results